Literature DB >> 21838087

Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy.

Raina Fumerton1, Nigel Ball, Youwen Zhou.   

Abstract

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare, acquired, idiopathic, nonneoplastic histiocytosis. In many cases the skin is involved and treatment is indicated. Various treatment options have been attempted with variable success. We report a case of cutaneous Rosai-Dorfman disease (CRDD) refractory to both topical and intralesional corticosteroid therapy that showed a rapid and remarkable response to cryotherapy. These observations suggest that cryotherapy should be considered as a therapeutic option for CRDD.

Entities:  

Mesh:

Year:  2011        PMID: 21838087

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  Cutaneous Rosai-Dorfman disease in a middle-aged man: A case report.

Authors:  Min Yang; Jianmin Chang
Journal:  Exp Ther Med       Date:  2015-06-18       Impact factor: 2.447

2.  NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.

Authors:  Kuan-Jou Wu; Shu-Hao Li; Jia-Bin Liao; Chien-Chun Chiou; Chieh-Shan Wu; Chien-Chin Chen
Journal:  Biology (Basel)       Date:  2021-05-02

3.  A Case of Cutaneous Rosai-Dorfman Disease Treated by Intralesional Injections of Glucocorticoid.

Authors:  Yan-Xia Yuan; Chun-Xing Xu; Ru-Zhi Zhang
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

4.  Purely cutaneous rosai-dorfman disease with immunohistochemistry.

Authors:  Uzma Farooq; Anna H Chacon; Vladimir Vincek; George W Elgart
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

5.  Cutaneous Rosai-Dorfman Disease: A Treatment Challenge.

Authors:  Anna Gawdzik; Bogna Ziarkiewicz-Wróblewska; Iwona Chlebicka; Alina Jankowska-Konsur; Jacek C Szepietowski; Joanna Maj
Journal:  Dermatol Ther (Heidelb)       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.